Clinical Trial Update: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nelarabine combined with etoposide and cyclophosphamide in relapsed T-cell ALL and T-cell lymphoblastic lymphoma; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)
• Nelarabine (Nelarabine)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-10-01